{"title":"Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-γ binding assay and transactivation and expression studies","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA06330A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA06330A\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,33247-33266<br /><b>DOI</b>: 10.1039/D4RA06330A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Priya D., Umme Hani, Nazima Haider, Sirajunisa Talath, Dhivya Shanmugarajan, Prabitha P., Archana P., B. R. Prashantha Kumar<br />The potential use of novel PPAR-γ agonists in the treatment of Alzheimer's disease.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"457f3b7fb7c6e75ebc8ed42bf666022324fc128079d61ec85194f204629f3b6e","category":"Environment"}